Literature DB >> 18090860

A quality-effects model for meta-analysis.

Suhail A R Doi1, Lukman Thalib.   

Abstract

We introduce a quality-effects approach that combines evidence from a series of trials comparing 2 interventions. This approach incorporates the heterogeneity of effects in the analysis of the overall interventional efficacy. However, unlike the random-effects model based on observed between-trial heterogeneity, we suggest adjustment based on measured methodological heterogeneity between studies. We propose a simple noniterative procedure for computing the combined effect size under this model and suggest that this could represent a more convincing alternative to the random effects model.

Mesh:

Year:  2008        PMID: 18090860     DOI: 10.1097/EDE.0b013e31815c24e7

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  60 in total

Review 1.  Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis.

Authors:  Annie-Claude M Lassemillante; Suhail A R Doi; John D Hooper; John B Prins; Olivia R L Wright
Journal:  Endocrine       Date:  2013-10-31       Impact factor: 3.633

Review 2.  Elevated bilirubin levels and risk of developing chronic kidney disease: a dose-response meta-analysis and systematic review of cohort studies.

Authors:  Jun Wang; Peng Guo; ZhengYan Gao; BenGang Zhou; Lei Ren; Yu Chen; Quan Zhou
Journal:  Int Urol Nephrol       Date:  2017-08-14       Impact factor: 2.370

Review 3.  Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy.

Authors:  Annie-Claude M Lassemillante; Suhail A R Doi; John D Hooper; John B Prins; Olivia R L Wright
Journal:  Endocrine       Date:  2015-01-31       Impact factor: 3.633

4.  Is it time for the Cochrane Collaboration to reconsider its meta-analysis methodology?

Authors:  Adedayo A Onitilo
Journal:  Clin Med Res       Date:  2014-02-26

Review 5.  Evidence synthesis for medical decision making and the appropriate use of quality scores.

Authors:  Suhail A R Doi
Journal:  Clin Med Res       Date:  2014-01-10

Review 6.  The burden of non-adherence to cardiovascular medications among the aging population in Australia: a meta-analysis.

Authors:  Samantha J McKenzie; Deirdre McLaughlin; Justin Clark; Suhail A R Doi
Journal:  Drugs Aging       Date:  2015-03       Impact factor: 3.923

7.  Thyroxine suppression therapy for benign, non-functioning solitary thyroid nodules: a quality-effects meta-analysis.

Authors:  Altayyeb Yousef; Justin Clark; Suhail A R Doi
Journal:  Clin Med Res       Date:  2010-08-25

Review 8.  Pain and its clinical associations in individuals with cystic fibrosis: A systematic review.

Authors:  Annemarie L Lee; Sarah Rawlings; Katharine A Bennett; David Armstrong
Journal:  Chron Respir Dis       Date:  2016-02-12       Impact factor: 2.444

9.  Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD.

Authors:  Patrícia Rebelo; Ana Oliveira; Cátia Paixão; Carla Valente; Lília Andrade; Alda Marques
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-01-29

Review 10.  Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.

Authors:  Gyanendra Kumar; Drew Uhrig; Susan Fowler; Matthew C DeLaney; Andrei V Alexandrov
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.